Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Monoclonal | 21 | 2025 | 866 | 4.080 |
Why?
|
| Enterotoxigenic Escherichia coli | 7 | 2023 | 22 | 2.650 |
Why?
|
| Lyme Disease | 6 | 2023 | 122 | 2.470 |
Why?
|
| Escherichia coli Infections | 6 | 2023 | 87 | 2.130 |
Why?
|
| Antibodies, Bacterial | 7 | 2023 | 194 | 2.040 |
Why?
|
| Lipoproteins | 6 | 2022 | 83 | 1.870 |
Why?
|
| Bacterial Outer Membrane Proteins | 6 | 2023 | 125 | 1.820 |
Why?
|
| Bacterial Vaccines | 5 | 2022 | 87 | 1.780 |
Why?
|
| Antibodies, Neutralizing | 7 | 2025 | 207 | 1.740 |
Why?
|
| Borrelia burgdorferi | 5 | 2023 | 90 | 1.650 |
Why?
|
| Epitopes | 7 | 2022 | 295 | 1.640 |
Why?
|
| Immunoglobulin A | 4 | 2022 | 97 | 1.610 |
Why?
|
| Single-Domain Antibodies | 2 | 2022 | 18 | 1.490 |
Why?
|
| Escherichia coli Vaccines | 3 | 2021 | 11 | 1.470 |
Why?
|
| Antigens, Surface | 5 | 2022 | 196 | 1.420 |
Why?
|
| Immunoglobulin A, Secretory | 6 | 2023 | 22 | 1.390 |
Why?
|
| Diarrhea | 3 | 2021 | 76 | 1.360 |
Why?
|
| Rabies virus | 2 | 2022 | 9 | 1.140 |
Why?
|
| Antibodies, Viral | 7 | 2023 | 319 | 1.120 |
Why?
|
| Spike Glycoprotein, Coronavirus | 4 | 2023 | 112 | 1.050 |
Why?
|
| Amino Acid Substitution | 4 | 2021 | 239 | 0.940 |
Why?
|
| Rabies Vaccines | 1 | 2022 | 4 | 0.780 |
Why?
|
| Rabies | 1 | 2022 | 8 | 0.780 |
Why?
|
| Animals | 30 | 2023 | 20579 | 0.750 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2022 | 46 | 0.740 |
Why?
|
| Ticks | 4 | 2023 | 35 | 0.730 |
Why?
|
| Immunoglobulin G | 7 | 2023 | 463 | 0.690 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 44 | 0.680 |
Why?
|
| Diphtheria Antitoxin | 2 | 2025 | 5 | 0.670 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2019 | 233 | 0.670 |
Why?
|
| Mice | 22 | 2023 | 10802 | 0.660 |
Why?
|
| Viral Envelope Proteins | 4 | 2017 | 102 | 0.610 |
Why?
|
| Hepacivirus | 2 | 2017 | 141 | 0.590 |
Why?
|
| Betacoronavirus | 1 | 2020 | 178 | 0.590 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2017 | 3 | 0.570 |
Why?
|
| Enteroendocrine Cells | 2 | 2007 | 6 | 0.560 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 266 | 0.560 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 58 | 0.520 |
Why?
|
| Disease Transmission, Infectious | 1 | 2016 | 23 | 0.500 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2016 | 24 | 0.490 |
Why?
|
| Diphtheria | 2 | 2025 | 6 | 0.490 |
Why?
|
| Immunologic Factors | 1 | 2016 | 104 | 0.480 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2174 | 0.460 |
Why?
|
| Diphtheria Toxin | 3 | 2025 | 7 | 0.460 |
Why?
|
| Corynebacterium diphtheriae | 1 | 2013 | 1 | 0.430 |
Why?
|
| Protein Engineering | 1 | 2014 | 82 | 0.420 |
Why?
|
| Protein Binding | 5 | 2020 | 1601 | 0.390 |
Why?
|
| Immunotherapy | 2 | 2021 | 250 | 0.390 |
Why?
|
| Humans | 31 | 2025 | 62678 | 0.390 |
Why?
|
| HEK293 Cells | 4 | 2020 | 618 | 0.380 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 1271 | 0.350 |
Why?
|
| Antigens, Viral | 1 | 2011 | 134 | 0.350 |
Why?
|
| Serotonin | 2 | 2007 | 60 | 0.340 |
Why?
|
| Glycoproteins | 1 | 2011 | 187 | 0.330 |
Why?
|
| Immunization, Passive | 3 | 2023 | 105 | 0.330 |
Why?
|
| Models, Molecular | 3 | 2020 | 1143 | 0.310 |
Why?
|
| Lyme Disease Vaccines | 3 | 2023 | 9 | 0.310 |
Why?
|
| Mice, Inbred C3H | 3 | 2019 | 176 | 0.310 |
Why?
|
| Drug Design | 2 | 2021 | 136 | 0.300 |
Why?
|
| Gastrointestinal Hormones | 1 | 2007 | 10 | 0.280 |
Why?
|
| Epitope Mapping | 2 | 2021 | 50 | 0.280 |
Why?
|
| Gastrointestinal Tract | 2 | 2020 | 180 | 0.280 |
Why?
|
| Wnt Proteins | 2 | 2007 | 98 | 0.280 |
Why?
|
| Retinoblastoma Protein | 1 | 2007 | 37 | 0.280 |
Why?
|
| Neutralization Tests | 4 | 2025 | 122 | 0.280 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 13 | 0.280 |
Why?
|
| Escherichia coli Proteins | 2 | 2021 | 271 | 0.280 |
Why?
|
| Antibody Specificity | 2 | 2020 | 103 | 0.270 |
Why?
|
| Adenoma | 1 | 2007 | 68 | 0.270 |
Why?
|
| beta Catenin | 1 | 2007 | 93 | 0.270 |
Why?
|
| Epitopes, B-Lymphocyte | 2 | 2023 | 18 | 0.250 |
Why?
|
| Cell Differentiation | 4 | 2018 | 1346 | 0.240 |
Why?
|
| Cell Cycle | 1 | 2007 | 393 | 0.240 |
Why?
|
| Administration, Oral | 3 | 2023 | 366 | 0.230 |
Why?
|
| Hepatitis C Antibodies | 2 | 2016 | 9 | 0.230 |
Why?
|
| Liver Transplantation | 3 | 2016 | 215 | 0.230 |
Why?
|
| Caco-2 Cells | 2 | 2021 | 70 | 0.220 |
Why?
|
| Transfection | 2 | 2019 | 691 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 3 | 2013 | 422 | 0.200 |
Why?
|
| Hepatitis C | 2 | 2016 | 151 | 0.200 |
Why?
|
| Borrelia burgdorferi Group | 1 | 2022 | 30 | 0.200 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2022 | 7 | 0.200 |
Why?
|
| Hepatitis C, Chronic | 2 | 2014 | 88 | 0.200 |
Why?
|
| Mutation | 4 | 2020 | 2573 | 0.190 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 47 | 0.180 |
Why?
|
| Camelids, New World | 1 | 2021 | 7 | 0.180 |
Why?
|
| Cross Protection | 1 | 2021 | 6 | 0.180 |
Why?
|
| Fimbriae Proteins | 1 | 2021 | 15 | 0.180 |
Why?
|
| Dogs | 1 | 2022 | 324 | 0.180 |
Why?
|
| Immunoconjugates | 1 | 2021 | 89 | 0.170 |
Why?
|
| Vero Cells | 1 | 2020 | 80 | 0.170 |
Why?
|
| Cross Reactions | 1 | 2020 | 131 | 0.170 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 86 | 0.170 |
Why?
|
| Macaca mulatta | 1 | 2021 | 248 | 0.170 |
Why?
|
| Aotidae | 1 | 2020 | 11 | 0.170 |
Why?
|
| Mutation, Missense | 1 | 2021 | 185 | 0.170 |
Why?
|
| Healthy Volunteers | 2 | 2025 | 76 | 0.160 |
Why?
|
| Receptors, IgE | 1 | 2019 | 5 | 0.160 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 80 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2019 | 61 | 0.160 |
Why?
|
| Antiviral Agents | 2 | 2023 | 321 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2154 | 0.150 |
Why?
|
| Plasmids | 1 | 2019 | 292 | 0.150 |
Why?
|
| Exosomes | 1 | 2018 | 47 | 0.140 |
Why?
|
| Mice, SCID | 1 | 2019 | 519 | 0.140 |
Why?
|
| Structural Homology, Protein | 1 | 2016 | 20 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2007 | 125 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 151 | 0.130 |
Why?
|
| Tick Bites | 1 | 2016 | 10 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2016 | 163 | 0.120 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 431 | 0.120 |
Why?
|
| Pregnancy Proteins | 1 | 2015 | 16 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 20 | 0.120 |
Why?
|
| Receptors, Fc | 1 | 2015 | 24 | 0.120 |
Why?
|
| Male | 5 | 2025 | 29483 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2015 | 72 | 0.110 |
Why?
|
| Binding Sites | 1 | 2016 | 900 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 670 | 0.110 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 46 | 0.110 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2015 | 144 | 0.110 |
Why?
|
| Lysine | 1 | 2014 | 82 | 0.110 |
Why?
|
| Guinea Pigs | 1 | 2013 | 84 | 0.110 |
Why?
|
| Gels | 1 | 2014 | 69 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2014 | 98 | 0.100 |
Why?
|
| Static Electricity | 1 | 2014 | 166 | 0.100 |
Why?
|
| Biological Evolution | 1 | 2014 | 119 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 48 | 0.100 |
Why?
|
| Temperature | 1 | 2014 | 309 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 455 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 127 | 0.100 |
Why?
|
| Cell Line | 2 | 2013 | 2038 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2013 | 576 | 0.090 |
Why?
|
| Intestines | 1 | 2013 | 166 | 0.090 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 227 | 0.090 |
Why?
|
| Binding Sites, Antibody | 1 | 2011 | 23 | 0.090 |
Why?
|
| Asparagine | 1 | 2011 | 24 | 0.090 |
Why?
|
| Sequence Analysis, Protein | 1 | 2011 | 34 | 0.090 |
Why?
|
| Mammals | 2 | 2023 | 217 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 247 | 0.090 |
Why?
|
| Point Mutation | 1 | 2011 | 165 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2023 | 453 | 0.090 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 383 | 0.090 |
Why?
|
| Female | 6 | 2025 | 32488 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2025 | 739 | 0.080 |
Why?
|
| RNA, Viral | 3 | 2016 | 272 | 0.080 |
Why?
|
| Biomarkers | 1 | 2014 | 1385 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5590 | 0.070 |
Why?
|
| Gastrin-Secreting Cells | 1 | 2008 | 1 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Antibody Affinity | 2 | 2021 | 19 | 0.070 |
Why?
|
| Ghrelin | 1 | 2007 | 18 | 0.070 |
Why?
|
| Glycosylation | 2 | 2021 | 138 | 0.070 |
Why?
|
| Cricetulus | 2 | 2019 | 100 | 0.070 |
Why?
|
| CHO Cells | 2 | 2019 | 190 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2007 | 117 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1139 | 0.060 |
Why?
|
| Exons | 1 | 2007 | 197 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 267 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2008 | 2097 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2023 | 898 | 0.060 |
Why?
|
| Receptors, LDL | 1 | 2004 | 34 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 99 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2008 | 3387 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 35 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2004 | 156 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 49 | 0.050 |
Why?
|
| Propidium | 1 | 2022 | 4 | 0.050 |
Why?
|
| Agglutination | 1 | 2022 | 5 | 0.050 |
Why?
|
| Immune Sera | 1 | 2022 | 35 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 35 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 207 | 0.050 |
Why?
|
| Protein Domains | 1 | 2022 | 148 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2023 | 219 | 0.050 |
Why?
|
| Gastric Acid | 1 | 2021 | 10 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 305 | 0.040 |
Why?
|
| Plants, Genetically Modified | 1 | 2021 | 23 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2020 | 48 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 2021 | 63 | 0.040 |
Why?
|
| Middle Aged | 3 | 2025 | 17363 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1594 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2008 | 1508 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2020 | 174 | 0.040 |
Why?
|
| Drug Stability | 1 | 2019 | 143 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2019 | 75 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2018 | 9 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 27 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 152 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 939 | 0.040 |
Why?
|
| Proteome | 1 | 2018 | 149 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 182 | 0.030 |
Why?
|
| Sustained Virologic Response | 1 | 2016 | 10 | 0.030 |
Why?
|
| Sofosbuvir | 1 | 2016 | 17 | 0.030 |
Why?
|
| Allografts | 1 | 2016 | 46 | 0.030 |
Why?
|
| Proof of Concept Study | 1 | 2016 | 37 | 0.030 |
Why?
|
| Transplant Recipients | 1 | 2016 | 33 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 16625 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2016 | 133 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1541 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 392 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2540 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 8 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 4633 | 0.030 |
Why?
|
| Half-Life | 1 | 2015 | 77 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 144 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 182 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 199 | 0.030 |
Why?
|
| Adolescent | 1 | 2025 | 6172 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 127 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 487 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 364 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 610 | 0.030 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2013 | 26 | 0.030 |
Why?
|
| Child | 1 | 2023 | 4444 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2013 | 26 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 126 | 0.030 |
Why?
|
| Mesoderm | 1 | 2013 | 84 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 60 | 0.030 |
Why?
|
| Tetraspanin 28 | 1 | 2012 | 4 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2013 | 105 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2012 | 34 | 0.020 |
Why?
|
| Neurons | 1 | 2018 | 909 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 288 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 634 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 260 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 987 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 229 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1992 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 774 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 1724 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 637 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2013 | 3022 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2445 | 0.020 |
Why?
|
| Pyloric Antrum | 1 | 2008 | 4 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2316 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 78 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 507 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 292 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 1333 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 837 | 0.010 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2004 | 4 | 0.010 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2004 | 5 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 324 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1528 | 0.010 |
Why?
|
| Proteins | 1 | 2004 | 750 | 0.010 |
Why?
|